Comparison between NAFLD fibrosis score and retinoic acid serum level in NAFLD

Ahmed A. Allam1, Mohamed Magdy Salama1, Haytham Mohamed Nasser2, Walaa Ahmed Yousry Kabiel3, Ehab H. Elsayed4
1Internal Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
2Radiology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
3Clinical Pathology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
4Tropical Medicine Department, National Research Center, Cairo, Egypt

Tóm tắt

Abstract Background Non-alcoholic fatty liver disease (NAFLD) is described by the abnormal accumulation of fats in livers of individuals without significant alcohol intake. It includes a spectrum of diseases from simple steatosis to steatohepatitis (NASH) with fibrosis and cirrhosis. The prevalence of NAFLD is rising in association with increasing obesity worldwide. Retinoic acid (RA), a metabolite of vitamin A, mediates the functions of vitamin A required for growth and development. Also, RA has been shown to reduce adiposity not only in fat cells but also in the liver through increasing triglyceride hydrolysis and fat oxidation. This could put a future trial of preventing NASH and cirrhosis development by vitamin A supplementation. This work aimed to study the role of retinoic acid in NAFLD, whether it can differentiate simple steatosis from NASH and correlate the result with the NAFLD fibrosis score. It is a cross-sectional study done on 180 patients divided into three groups. Group 1 is composed of 80 patients with simple steatosis and normal ALT; group 2 is composed of 80 patients with NASH and high ALT in addition to group 3 with 20 healthy subjects served as a control group. All patients were proven to have fatty liver by ultrasonography. Serum RA was assayed by using enzyme-linked immunosorbent assay (ELISA) technique, and the NAFLD fibrosis score was calculated and compared with the retinoic acid level. Result Serum RA level was significantly decreased in the patient groups as compared to the controls; the lowest serum level was observed among the NASH group, followed by the steatosis group. NAFLD fibrosis score was calculated, and it was higher in the NASH group than in the steatosis group. Besides, there was a significant negative correlation between retinoic acid and NAFLD score among the patient groups. Conclusion Serum RA level was lower in patients with simple steatosis and NASH. RA had a high statistically significant difference in differentiation between the patient groups and the control group. The results were comparable to the NAFLD fibrosis score. Thus, retinoic acid could be used for diagnosis and accessing the degree of NAFLD.

Từ khóa


Tài liệu tham khảo

Hazlehurst JM, and Tomlinson JW (2013)Non-alcoholic fatty liver disease in common endocrine disorders 169:R27-37. doi: https://doi.org/10.1530/EJE-13-0296

Nascimbeni F, Pais R, Bellentani S et al (2013) From NAFLD in clinical practice to answers from guidelines. J Hepatol 59:859–871

Zhu JZ, Dai YN, Wang YM et al (2015) Prevalence of nonalcoholic fatty liver disease and economy. Dig Dis Sci 60:3194–3202

Bell LN, Theodorakis JL, Vuppalanchi R et al (2010) Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease. Hepatology 51:111–120

Chalasani N, Younossi Z, Lavine JE et al (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the Amer-ican Gastroenterological Association. Hepatology 55:2005–2023

Ratziu V, Giral P, Charlotte F et al (2000) Liver fibrosis in overweight patients. Gastroenterology 118:1117–1123

Angulo P, Hui JM, Marchesini G et al (2007) The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45:846–854

Machado MV, Cortex-Pinto H (2013) Noninvasive diagnosis of non-alcoholic fatty liver disease: A critical appraisal. J Hepatol 58:1007–1019

Kam RK, Deng Y, Chen Y. et al. (2012) Retinoic acid synthesis and functions in early embyronic developement Cell Biosci 2: 11.

Mondul A, Mancina RM, Merlo A et al (2015) PNPLA3 I148M variant influences circulating retinol in adults with nonalcoholic fatty liver disease or obesity. J Nutr 145:1687–1691

Senoo H, Yoshikawa K, Morii M et al (2010) Hepatic stellate cell (vitamin A-stor-ing cell) and it’s relative – past, present and future. Cell Biol Int 34:1247–1272

Rinella M.(2015)Non-alcoholic fatty liver disease: a systematic review313:2263-73. doi: https://doi.org/10.1001/jama.2015.5370.

Bonet ML, Ribot J, Palou A (2012) Lipid metabolism in mammalian tissues and its control by retinoic acid. Biochim Biophys Acta 1821:177–189

Liu Y, Chen H, Wang J et al (2015) Association of serum retinoic acid with hepatic steatosis and liver injury in non-alcoholic fatty liver disease. Am J Clin Nutr 102:130–137

Chaves G, Pereira SE, Saboya CJ et al (2008) Non-alcoholic Fatty Liver Disease and Its Relationship with the Nutritional Status of Vitamin A in Individuals with Class III Obesity. Obes Surg 18:378. https://doi.org/10.1007/s11695-007-9361-2

Botella-Carretero JI, Balsa JA, Vázquez C et al (2010) Retinol and alpha-tocopherol in morbid obesity and nonalcoholic fatty liver disease. Obes Surg 20:69–76

Miyazaki M, Kato M, Tanaka K et al (2012) Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism. Mol Med Rep 5:729–733

Mourad F, El Sayeda Z, Showmana H, Abo RM, Mohamed N (2018) The role of serum retinol in nonalcoholic fatty liver disease. Sci J Al-Azhar Med Fac Girls 2:115–122

Pettinelli P, Arendt BM, Teterina A, McGilvray I, Comelli EM, Fung SK, Fischer SE, Allard JP (2018) Altered hepatic genes related to retinol metabolism and plasma retinol in patients with non-alcoholic fatty liver disease. PLoS One. 13:e0205747

Cengiz C, Ardicoglu Y, Bulut S, Boyacioglu S (2010) Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis? Eur J Gastroenterol Hepatol 22:813–819

Alkhouri N, Lopez R, Berk M, Feldstein A (2009) Serum retinol-binding protein 4 levels in patients with nonalcoholic fatty liver disease. J Clin Gastroenterol 43:985–989